| CLA1681 |
|
906068-56-2 |
西拉利珠單抗
Theralizumab | TGN1412 | TAB-08 | TABO8
3-5days
95+%
|
￥3236.00 |
— |
|
|
|
| CLA1360 |
|
1442657-12-6 |
帕妥昔珠單抗
Pasotuxizumab
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1356 |
|
1630074-14-4 |
地寧妥珠單抗
Denintuzumab (Anti-CD19)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1354 |
|
946415-62-9 |
昂妥昔珠單抗
Ontuxizumab (Anti-TEM1 / Endosialin / CD248)
3-5days
95+%
|
￥3200.00 |
— |
|
|
|
| CLA1353 |
|
1269764-99-9 |
考妥昔單抗
Coltuximab (Anti-CD19)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1345 |
|
1416147-64-2 |
達匹利珠單抗
Dapirolizumab pegol
3-5days
95+%
|
￥6200.00 |
— |
|
|
|
| CLA1324 |
|
1313706-14-7 |
匹那妥珠單抗
Pinatuzumab (Anti-Siglec-2 / CD22)
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1308 |
|
1169956-08-4 |
奧卡妥珠單抗
Ocaratuzumab (Anti-CD20)
3-5days
95+%
|
￥3600.00 |
— |
|
|
|
| CLA1293 |
|
1005198-65-1 |
索利托單抗
Solitomab
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1287 |
|
1238217-55-4 |
伐利組單抗
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1282 |
|
1188275-92-4 |
那吶妥單抗
Narnatumab (Anti-MSPR / RON / CD136)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1275 |
|
934823-49-1 |
烏瑞蘆單抗
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)
3-5days
95+%
|
￥5500.00 |
— |
|
|
|
| CLA1274 |
|
1174014-05-1 |
烏妥昔單抗
Ublituximab (Anti-CD20)
3-5days
95+%
|
￥3500.00 |
— |
|
|
|
| CLA1273 |
|
1207446-68-1 |
曲利組單抗
Tregalizumab (Anti-CD4)
3-5days
95+%
|
￥4500.00 |
— |
|
|
|
| CLA1260 |
|
1073059-33-2 |
沙馬組單抗
Samalizumab (Anti-CD200)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1259 |
|
1174008-79-7 |
羅來度單抗
Roledumab (Anti-RHD / CD240d)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1258 |
|
1186098-83-8 |
奧塞蘆單抗
Oxelumab (Anti-TNFSF4 / OX40L / CD252)
3-5days
95+%
|
￥1800.00 |
— |
|
|
|
| CLA1255 |
|
1116433-11-4 |
伊利組單抗
Itolizumab (Anti-CD6)
3-5days
95+%
|
￥4000.00 |
— |
|
|
|
| CLA1254 |
|
946415-64-1 |
福雷蘆單抗
Foralumab (Anti-CD3e)
3-5days
95+%
|
￥2500.00 |
— |
|
|
|
| CLA1228 |
|
158318-63-9 |
貝妥莫單抗
Bectumomab
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
